Related Experiment Video
Updated: Jun 19, 2026
09:57
In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
Progesterone and dexamethasone differentially regulate the IGF-system in glial cells.
Daniel Chesik1, Jacques De Keyser
1Department of Neurology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. d.chesik@med.umcg.nl
Neuroscience Letters
|October 27, 2009
Summary
Progesterone boosts Insulin-like Growth Factor-1 (IGF-1) system in glial cells, aiding myelin repair for demyelinating diseases. Dexamethasone, however, inhibits this system and oligodendrocyte differentiation.
Area of Science:
- Neuroscience
- Endocrinology
- Cell Biology
Background:
- Insulin-like Growth Factor-1 (IGF-1) is crucial for myelin synthesis and shows therapeutic promise for demyelinating diseases like multiple sclerosis.
- IGF-1's limited blood-brain barrier penetration necessitates exploring alternative regulatory mechanisms in glial cells.
Purpose of the Study:
- To investigate the regulatory effects of progesterone and dexamethasone on the IGF-system in glial cells.
- To determine the impact of these steroids on oligodendrocyte differentiation and migration.
Main Methods:
- Quantitative PCR analysis was used to assess gene expression levels of IGF-1, IGF receptor, and IGF binding proteins in primary rat astrocytes and OLN-93 oligodendroglial progenitor cells.
- Expression of the oligodendrocyte differentiation marker CNPase was evaluated.
- Oligodendroglial cell migration was quantified.
Main Results:
- Progesterone upregulated IGF-1, type 1 IGF receptor, and IGFBP-2 in astrocytes, and IGF-1 and IGFBP-6 in oligodendroglial progenitor cells.
- Dexamethasone negatively affected the expression of IGF-1, type 1 IGF receptor, and IGF binding proteins in both cell types.
- Progesterone positively regulated CNPase and enhanced oligodendroglial cell migration by approximately 4-fold, while dexamethasone had opposite effects.
Conclusions:
- Progesterone acts as a positive regulator of the IGF-system in glial cells, supporting oligodendrocyte biology and progenitor cell migration.
- Dexamethasone functions as a negative regulator of the IGF-system in glial cells.
- These findings highlight potential therapeutic avenues for demyelinating diseases by modulating steroid hormone effects on glial cells and the IGF-system.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...